Drugs that cause pulmonary toxicity. Drugs that cause pulmonary toxicity. The Medical letter on drugs and therapeutics [No authors listed] PMID: 2402221 Med Lett Drugs Ther. 1990 Sep 21;32(827):88-90. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Drugs that cause pulmonary toxicity. Med Lett Drugs Ther. 1990;32(827):88-90 APA (1990). Drugs that cause pulmonary toxicity. The Medical letter on drugs and therapeutics, 32(827), 88-90. MLA "Drugs that cause pulmonary toxicity." The Medical letter on drugs and therapeutics vol. 32,827 (1990): 88-90. NLM Drugs that cause pulmonary toxicity. Med Lett Drugs Ther. 1990 Sep 21;32(827):88-90. PMID: 2402221. Copy Download .nbib Format: NLM AMA APA MLA NLM
Addendum: estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms. Addendum: estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms. The Medical letter on drugs and therapeutics [No authors listed] PMID: 31381553 Med Lett Drugs Ther. 2019 Jul 29;61(1577):120. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Addendum: estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms. Med Lett Drugs Ther. 2019;61(1577):120 APA (2019). Addendum: estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms. The Medical letter on drugs and therapeutics, 61(1577), 120. MLA "Addendum: estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms." The Medical letter on drugs and therapeutics vol. 61,1577 (2019): 120. NLM Addendum: estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms. Med Lett Drugs Ther. 2019 Jul 29;61(1577):120. PMID: 31381553. Copy Download .nbib Format: NLM AMA APA MLA NLM
Pemigatinib (Pemazyre) for cholangiocarcinoma. Pemigatinib (Pemazyre) for cholangiocarcinoma. The Medical letter on drugs and therapeutics [No authors listed] PMID: 33451178 Med Lett Drugs Ther. 2018 May 07;60(1546):e208-e209. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Pemigatinib (Pemazyre) for cholangiocarcinoma. Med Lett Drugs Ther. 2018;60(1546):e208-e209 APA (2018). Pemigatinib (Pemazyre) for cholangiocarcinoma. The Medical letter on drugs and therapeutics, 60(1546), e208-e209. MLA "Pemigatinib (Pemazyre) for cholangiocarcinoma." The Medical letter on drugs and therapeutics vol. 60,1546 (2018): e208-e209. NLM Pemigatinib (Pemazyre) for cholangiocarcinoma. Med Lett Drugs Ther. 2018 May 07;60(1546):e208-e209. PMID: 33451178. Copy Download .nbib Format: NLM AMA APA MLA NLM
In brief: Guillain-Barré syndrome with the Johnson and Johnson COVID-19 vaccine. In brief: Guillain-Barré syndrome with the Johnson and Johnson COVID-19 vaccine. The Medical letter on drugs and therapeutics [No authors listed] PMID: 34550109 Med Lett Drugs Ther. 2021 Aug 09;63(1630):121. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA In brief: Guillain-Barré syndrome with the Johnson and Johnson COVID-19 vaccine. Med Lett Drugs Ther. 2021;63(1630):121 APA (2021). In brief: Guillain-Barré syndrome with the Johnson and Johnson COVID-19 vaccine. The Medical letter on drugs and therapeutics, 63(1630), 121. MLA "In brief: Guillain-Barré syndrome with the Johnson and Johnson COVID-19 vaccine." The Medical letter on drugs and therapeutics vol. 63,1630 (2021): 121. NLM In brief: Guillain-Barré syndrome with the Johnson and Johnson COVID-19 vaccine. Med Lett Drugs Ther. 2021 Aug 09;63(1630):121. PMID: 34550109. Copy Download .nbib Format: NLM AMA APA MLA NLM
Table: Safety of drugs for IBS in pregnancy and lactation (online only). Table: Safety of drugs for IBS in pregnancy and lactation (online only). The Medical letter on drugs and therapeutics [No authors listed] PMID: 32324174 Med Lett Drugs Ther. 2020 Mar 23;62(1594):e48-e49. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Table: Safety of drugs for IBS in pregnancy and lactation (online only). Med Lett Drugs Ther. 2020;62(1594):e48-e49 APA (2020). Table: Safety of drugs for IBS in pregnancy and lactation (online only). The Medical letter on drugs and therapeutics, 62(1594), e48-e49. MLA "Table: Safety of drugs for IBS in pregnancy and lactation (online only)." The Medical letter on drugs and therapeutics vol. 62,1594 (2020): e48-e49. NLM Table: Safety of drugs for IBS in pregnancy and lactation (online only). Med Lett Drugs Ther. 2020 Mar 23;62(1594):e48-e49. PMID: 32324174. Copy Download .nbib Format: NLM AMA APA MLA NLM
In brief: Johnson & Johnson COVID-19 vaccine suspended. In brief: Johnson & Johnson COVID-19 vaccine suspended. The Medical letter on drugs and therapeutics [No authors listed] PMID: 33976102 Med Lett Drugs Ther. 2021 May 03;63(1623):e1. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA In brief: Johnson & Johnson COVID-19 vaccine suspended. Med Lett Drugs Ther. 2021;63(1623):e1 APA (2021). In brief: Johnson & Johnson COVID-19 vaccine suspended. The Medical letter on drugs and therapeutics, 63(1623), e1. MLA "In brief: Johnson & Johnson COVID-19 vaccine suspended." The Medical letter on drugs and therapeutics vol. 63,1623 (2021): e1. NLM In brief: Johnson & Johnson COVID-19 vaccine suspended. Med Lett Drugs Ther. 2021 May 03;63(1623):e1. PMID: 33976102. Copy Download .nbib Format: NLM AMA APA MLA NLM
Addendum: Diet, Drugs, and Surgery for Weight Loss. Addendum: Diet, Drugs, and Surgery for Weight Loss. The Medical letter on drugs and therapeutics [No authors listed] PMID: 26845779 Med Lett Drugs Ther. 2015 Apr 27;57(1467):66. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Addendum: Diet, Drugs, and Surgery for Weight Loss. Med Lett Drugs Ther. 2015;57(1467):66 APA (2015). Addendum: Diet, Drugs, and Surgery for Weight Loss. The Medical letter on drugs and therapeutics, 57(1467), 66. MLA "Addendum: Diet, Drugs, and Surgery for Weight Loss." The Medical letter on drugs and therapeutics vol. 57,1467 (2015): 66. NLM Addendum: Diet, Drugs, and Surgery for Weight Loss. Med Lett Drugs Ther. 2015 Apr 27;57(1467):66. PMID: 26845779. Copy Download .nbib Format: NLM AMA APA MLA NLM
Addendum: Drospirenone (Slynd) - a new progestin-only oral contraceptive. Addendum: Drospirenone (Slynd) - a new progestin-only oral contraceptive. The Medical letter on drugs and therapeutics [No authors listed] PMID: 32324173 Med Lett Drugs Ther. 2020 Mar 23;62(1594):48. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Addendum: Drospirenone (Slynd) - a new progestin-only oral contraceptive. Med Lett Drugs Ther. 2020;62(1594):48 APA (2020). Addendum: Drospirenone (Slynd) - a new progestin-only oral contraceptive. The Medical letter on drugs and therapeutics, 62(1594), 48. MLA "Addendum: Drospirenone (Slynd) - a new progestin-only oral contraceptive." The Medical letter on drugs and therapeutics vol. 62,1594 (2020): 48. NLM Addendum: Drospirenone (Slynd) - a new progestin-only oral contraceptive. Med Lett Drugs Ther. 2020 Mar 23;62(1594):48. PMID: 32324173. Copy Download .nbib Format: NLM AMA APA MLA NLM
In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted. In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted. The Medical letter on drugs and therapeutics [No authors listed] PMID: 33976095 Med Lett Drugs Ther. 2021 May 17;63(1624):e1. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted. Med Lett Drugs Ther. 2021;63(1624):e1 APA (2021). In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted. The Medical letter on drugs and therapeutics, 63(1624), e1. MLA "In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted." The Medical letter on drugs and therapeutics vol. 63,1624 (2021): e1. NLM In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted. Med Lett Drugs Ther. 2021 May 17;63(1624):e1. PMID: 33976095. Copy Download .nbib Format: NLM AMA APA MLA NLM
Eteplirsen (Exondys 51) for duchenne muscular dystrophy. Eteplirsen (Exondys 51) for duchenne muscular dystrophy. The Medical letter on drugs and therapeutics [No authors listed] PMID: 27805575 Med Lett Drugs Ther. 2016 Nov 07;58(1507):145-146. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Eteplirsen (Exondys 51) for duchenne muscular dystrophy. Med Lett Drugs Ther. 2016;58(1507):145-146 APA (2016). Eteplirsen (Exondys 51) for duchenne muscular dystrophy. The Medical letter on drugs and therapeutics, 58(1507), 145-146. MLA "Eteplirsen (Exondys 51) for duchenne muscular dystrophy." The Medical letter on drugs and therapeutics vol. 58,1507 (2016): 145-146. NLM Eteplirsen (Exondys 51) for duchenne muscular dystrophy. Med Lett Drugs Ther. 2016 Nov 07;58(1507):145-146. PMID: 27805575. Copy Download .nbib Format: NLM AMA APA MLA NLM
